Trial Profile
Efficacy and safety of sucroferric oxyhydroxide on hemodialysis patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Jun 2018
Price :
$35
*
At a glance
- Drugs Sucroferric oxyhydroxide (Primary) ; Lanthanum carbonate
- Indications Hyperphosphataemia
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 06 Jun 2018 New trial record